Chinese Journal of Organic Chemistry ›› 2026, Vol. 46 ›› Issue (8): 3079-3088.DOI: 10.6023/cjoc202603042 Previous Articles     Next Articles

ARTICLES

新型香豆素衍生物的合成及其抗非小细胞肺癌活性研究

朱凯a, 邢琳a, 李璐璐a, 范君婷b, 盛瑞隆c, 郭锐华a,*()   

  1. a 上海海洋大学食品学院 海洋药物教研室 中国上海 201306
    b 南京医科大学药学院 药物分析学系 中国南京 211166
    c 马德拉大学木材化学研究中心(CQM) 葡萄牙丰沙尔市佩恩特阿达校区 9000-390
  • 收稿日期:2026-03-30 修回日期:2026-04-25 发布日期:2026-06-03
  • 通讯作者: 郭锐华
  • 基金资助:
    国家自然科学基金(82173731); 国家自然科学基金(81502955)

Synthesis and Anti-Non-Small Cell Lung Cancer Activity of Novel Coumarin Derivatives

Kai Zhua, Lin Xinga, Lulu Lia, Junting Fanb, Ruilong Shengc, Ruihua Guoa,*()   

  1. a Department of Marine Drugs, College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China
    b Department of Pharmaceutical Analysis, School of Pharmacy, Nanjing Medical University, Nanjing 211166, China
    c Centro de Química da Madeira (CQM), Universidade da Madeira, Campus da Penteada, Funchal 9000-390, Portugal
  • Received:2026-03-30 Revised:2026-04-25 Published:2026-06-03
  • Contact: Ruihua Guo
  • Supported by:
    National Natural Science Foundation of China(82173731); National Natural Science Foundation of China(81502955)

A series of novel coumarin derivatives 1~15 were synthesized and evaluated for their anticancer activity against A549 cell. Most derivatives showed moderate inhibitory activities. Among them, 4-(chloromethyl)-2-oxo-2H-chromene-7,8- diyl diacetate (2), 3-benzyl-7-((2-chloropyrimidin-4-yl)oxy)-4-methyl-2H-chromen-2-one (13), 3-benzyl-4-methyl-2-oxo-2H- chromene-7,8-diyl diacetate (14) and 3-benzyl-4-methyl-2-oxo-2H-chromene-7,8-diyl dipropionate (15) presented remarkable bioactivities with IC50 values range from (4.7±0.7) to (17.9±2.1) μmol/L. Derivative 13 exhibited remarkable inhibitory activity against A549 (IC50=4.7±0.7 μmol/L) in vitro. Network pharmacology analysis of derivative 13 yielded a total of 166 intersecting targets. The protein-protein interaction (PPI) network identified epidermal growth factor receptor (EGFR) as a key target, and enrichment analysis suggested that derivative 13 may exert its anti-lung cancer effects through multi target regulation of key signaling pathways associated with cell survival and proliferation. Docking analysis showed that derivative 13 exhibited a docking score of -33.18 kJ/mol for EGFR. It was found to exert potential regulatory effects on the EGFR by interacting with Ser-784, Arg-748, and Lys-754 residues. Additionally, derivative 13 significantly affected the cell cycle of A549 cells, inducing G0/G1-phase arrest. Thus, these results suggest that derivative 13 is a promising lead compound for the treatment of non-small cell lung cancer.

Key words: coumarin, derivative, structure activity relationships, lung cancer